Expanded Access Services · Proposed
Explore the questions around expanded access.
-
Physician-Led Pathways and Proposed Navigation Support
Start a Conversation
Expanded Access Services · Proposed
A possible pathway needs the right clinical and program decisions.
Expanded access can be a potential route to an investigational medicine outside a clinical trial for some people with a serious or life-threatening condition and no adequate treatment alternative. Requirements differ by jurisdiction and program.
Fanoni is exploring a navigation role around these pathways. Expanded access operations are not an active Fanoni service. A treating clinician and the responsible sponsor or program team must assess whether a pathway exists and what requirements apply.
Begin with the treating clinician. Confirm the program. Agree any support.
Clinical Conversation
Program Confirmation
From the Question to the Next Step
A proposed role around practical questions.
Understand the Pathway
Prepare questions about the investigational medicine, alternatives and the people responsible for the request. Read the FDA’s official expanded access overview for the US context.
Clarify Program Responsibilities
A proposed collaboration would define physician, sponsor, provider and administrative responsibilities. Fanoni does not offer drug supply, regulatory submissions or program authorization here.
Plan the Communication
Explore how an agreed administrative service might keep contacts, questions and next steps clear. No request can be submitted to an active access program through this website.
Information is the starting point.
Investigational medicines have not been established as safe and effective for the proposed use. A pathway depends on separate clinical, sponsor, program and applicable regulatory decisions.
Fanoni does not approve treatment, guarantee access or distribute medicines. Learn more from the FDA expanded access overview and your treating team.
Discuss the Options
Confirm the Program
Define Responsibilities
Review Next Steps
Questions Before Your Next Step
Is expanded access a clinical trial?
Expanded access involves investigational treatment outside a clinical trial under the applicable rules. The FDA source below explains the United States pathway; requirements differ elsewhere. Fanoni’s operational support remains proposed.
Sources and Further Reading
These sources provide background. They do not endorse Fanoni or confirm access to a provider or study.
Speak With Fanoni
Discuss a proposed navigation role.
For sponsor and program teams: share the administrative question you want to explore. This inquiry does not create an access program or request medicine.
Program Inquiry
Your inquiry is saved in Fanoni’s private website inbox for the team to review. Keep your request general and do not include patient or medical details.